Redenlab’s Chief Science Officer, Adam P. Vogel, PhD, leads groundbreaking study on speech analysis for neurodegenerative diseases

    MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a groundbreaking study...
    Read more

    Acoustic analysis of the effects of sustained wakefulness on speech

      Exposing healthy adults to extended periods of wakefulness is known to induce changes in psychomotor functioning. The effect of fatigue...
      Read more

      Perceptual and acoustic analysis of speech in spinocerebellar ataxia type 1

        Speech is a cardinal and important feature of ataxia. We have put together a comprehensive description of dysarthria in spinocerebellar...
        Read more

        Listener detection of objectively validated acoustic features of speech in Huntington’s Disease

          Subtle progressive changes in speech motor function and cognition begin prior to diagnosis of Huntington's disease (HD). Scientists at University...
          Read more

          NEW: Redenlab commence work with Melbourne Brain Centre & The University of Melbourne on speech testing for clinical trial in Dravet Syndrome

            Read more